Mechanism and Structure Based Design of Inhibitors of AMP and Adenosine Deaminase

2021 ◽  
pp. 116272
Author(s):  
Stephen D. Lindell ◽  
Simon Maechling ◽  
Robert Klein ◽  
Jörg Freigang ◽  
Bernd Laber ◽  
...  
Keyword(s):  
2011 ◽  
Vol 3 (10) ◽  
pp. 1-3 ◽  
Author(s):  
Dr. Amit P Trivedi ◽  
◽  
Dr. Kiran P Chauhan ◽  
Dr. N Haridas Dr. N Haridas

2016 ◽  
Vol 3 (4) ◽  
pp. 75-79
Author(s):  
B. Praveen Kumar ◽  
◽  
C. Venkateshwarlu ◽  
M. Narendra ◽  
◽  
...  

Open Medicine ◽  
2021 ◽  
Vol 16 (1) ◽  
pp. 387-396
Author(s):  
Sing-Ting Wang ◽  
Chieh-Lung Chen ◽  
Shih-Hsin Liang ◽  
Shih-Peng Yeh ◽  
Wen-Chien Cheng

Abstract Pleural effusions are rarely observed in association with acute myeloid leukemia (AML), and their true incidence remains unknown. Given the low diagnostic yield from cytopathologic analysis of malignant pleural effusions and the fact that patients with leukemia are often thrombocytopenic and unable to tolerate invasive procedures, the incidence of leukemic effusions may be underestimated. Here, we report a rare case of pleural effusion in a patient with newly diagnosed AML. Initial analysis revealed an exudative, lymphocyte-predominant effusion. High levels of adenosine deaminase (ADA) were detected in pleural fluid, consistent with a diagnosis of tuberculosis. However, the analysis of pleural cytology revealed leukemic cells, permitting the diagnosis of leukemic effusion to be made. The patient underwent induction chemotherapy and pleural effusion resolved without recurrence. This case emphasizes the diagnostic dilemma presented by high levels of ADA in a leukemic pleural effusion, as this association has not been previously considered in the literature.


Sign in / Sign up

Export Citation Format

Share Document